Related Experiment Video
Updated: May 16, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac
Ulas Höke1, Joep Thijssen, Rutger J van Bommel
1Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands.
Insights
Diabetic patients show less improvement in heart function after cardiac resynchronization therapy (CRT) and have worse long-term outcomes. Diabetes independently predicts mortality in heart failure patients receiving CRT.
Area of Science:
- Cardiology
- Diabetology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) effectiveness in diabetic heart failure patients is not well understood.
- Assessing the impact of diabetes on CRT outcomes is crucial for personalized treatment.
Purpose of the Study:
- To evaluate changes in left ventricular (LV) systolic and diastolic function in CRT recipients with and without diabetes.
- To assess the long-term prognosis of diabetic patients undergoing CRT.
Main Methods:
- A registry study included 710 CRT recipients (171 with diabetes).
- Echocardiography assessed LV function at baseline and 6 months.
- Response to CRT defined as ≥15% reduction in LV end-systolic volume (LVESV).
- Long-term follow-up recorded all-cause mortality and cardiac events.
Main Results:
- Diabetic patients had a lower CRT response rate (45% vs. 57%) and less pronounced LV diastolic function improvement.
- Diabetes, LV dyssynchrony, ischemic cardiomyopathy, and insulin use were key factors in diabetic CRT response.
- Diabetic patients experienced significantly higher rates of mortality and cardiac events (P < 0.001).
- Diabetes independently predicted all-cause mortality, along with other factors like LVESV and diastolic dysfunction.
Conclusions:
- Diabetic heart failure patients benefit from CRT with improved LV function, but less so than non-diabetics.
- Diabetes is an independent predictor of mortality in CRT recipients.
Objective:
The influence of diabetes on cardiac resynchronization therapy (CRT) remains unclear. The aims of the current study were to 1) assess the changes in left ventricular (LV) systolic and diastolic function and 2) evaluate long-term prognosis in CRT recipients with diabetes.
Research Design And Methods:
A total of 710 CRT recipients (171 with diabetes) were included from an ongoing registry. Echocardiographic evaluation, including LV systolic and diastolic function assessment, was performed at baseline and 6-month follow-up. Response to CRT was defined as a reduction of ≥15% in LV end-systolic volume (LVESV) at the 6-month follow-up. During long-term follow-up (median = 38 months), all-cause mortality (primary end point) and cardiac death or heart failure hospitalization (secondary end point) were recorded.
Results:
At the 6-month follow-up, significant LV reverse remodeling was observed both in diabetic and non-diabetic patients. However, the response to CRT occurred more frequently in non-diabetic patients than in diabetic patients (57 vs. 45%, P < 0.05). Furthermore, a significant improvement in LV diastolic function was observed both in diabetic and non-diabetic patients, but was more pronounced in non-diabetic patients. The determinants of the response to CRT among diabetic patients were LV dyssynchrony, ischemic cardiomyopathy, and insulin use. Both primary and secondary end points were more frequent in diabetic patients (P < 0.001). Particularly, diabetes was independently associated with all-cause mortality together with ischemic cardiomyopathy, renal function, LVESV, LV dyssynchrony, and LV diastolic dysfunction.
Conclusions:
Heart failure patients with diabetes exhibit significant improvements in LV systolic and diastolic function after CRT, although they are less pronounced than in non-diabetic patients. Diabetes was independently associated with all-cause mortality.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

